Loading...
Nova Eye Medical Limited
ELXMF•PNK
Healthcare
Medical - Devices
$0.10
$0.00(0.00%)
Nova Eye Medical Limited (ELXMF) Financial Performance & Income Statement Overview
Review Nova Eye Medical Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
37.004%
↑ 37.004%
Operating Income Growth
67.96%
↑ 67.96%
Net Income Growth
42.52%
↑ 42.52%
Operating Cash Flow Growth
-16.90%
↓ 16.90%
Operating Margin
-27.40%
↓ 27.40%
Gross Margin
53.94%
↑ 53.94%
Net Profit Margin
-37.68%
↓ 37.68%
ROE
-45.84%
↓ 45.84%
ROIC
-26.41%
↓ 26.41%
Nova Eye Medical Limited (ELXMF) Income Statement & Financial Overview
Review Nova Eye Medical Limited's (ELXMF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $13.19M | $10.14M | $8.63M | $8.39M |
| Cost of Revenue | $1.93M | $8.82M | $7.21M | $8.98M |
| Gross Profit | $11.26M | $1.32M | $1.43M | -$586000.00 |
| Gross Profit Ratio | $0.85 | $0.13 | $0.17 | -$0.07 |
| R&D Expenses | $567000.00 | $0.00 | $617000.00 | $0.00 |
| SG&A Expenses | $11.48M | $6.93M | $4.09M | $6.65M |
| Operating Expenses | $12.05M | $6.93M | $6.06M | $6.42M |
| Total Costs & Expenses | $13.97M | $15.74M | $13.27M | $15.39M |
| Interest Income | $73000.00 | $51000.00 | $68000.00 | $35000.00 |
| Interest Expense | $58000.00 | $12000.00 | $25000.00 | $29000.00 |
| Depreciation & Amortization | $1.57M | $1.42M | $1.18M | $1.11M |
| EBITDA | -$1.54M | -$4.18M | -$3.36M | -$5.89M |
| EBITDA Ratio | -$0.12 | -$0.41 | -$0.40 | -$0.70 |
| Operating Income | -$786000.00 | -$5.61M | -$4.63M | -$7.004M |
| Operating Income Ratio | -$0.06 | -$0.55 | -$0.54 | -$0.83 |
| Other Income/Expenses (Net) | -$2.38M | -$19000.00 | -$6.91M | -$30000.00 |
| Income Before Tax | -$3.17M | -$5.63M | -$9.97M | -$7.03M |
| Income Before Tax Ratio | -$0.24 | -$0.55 | -$1.15 | -$0.84 |
| Income Tax Expense | $0.00 | $0.00 | -$1.28M | -$429000.00 |
| Net Income | -$3.17M | -$5.63M | -$8.69M | -$6.61M |
| Net Income Ratio | -$0.24 | -$0.55 | -$1.006 | -$0.79 |
| EPS | -$0.01 | -$0.03 | -$0.05 | -$0.04 |
| Diluted EPS | -$0.01 | -$0.03 | -$0.05 | -$0.04 |
| Weighted Avg Shares Outstanding | $217.03M | $195.77M | $169.12M | $149.74M |
| Weighted Avg Shares Outstanding (Diluted) | $217.60M | $195.77M | $169.12M | $149.74M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan